Literature DB >> 10078640

Use of pelvic CT scanning to evaluate pubic arch interference of transperineal prostate brachytherapy.

J Bellon1, K Wallner, W Ellis, K Russell, W Cavanagh, J Blasko.   

Abstract

PURPOSE: To determine the necessity of preoperative evaluation of pubic arch interference in patients with small prostate volumes. METHODS AND MATERIALS: CT scans from 97 consecutive, unselected patients with stage T1 or T2 prostatic carcinoma who had transperineal I-125 or Pd-103 implants at the University of Washington in 1997 were analyzed for pubic arch interference. Transrectal ultrasound (TRUS) was performed with 6.0-MHz transducer with the patient in the lithotomy position and the patient's thighs vertical, similar to that used during the implant procedure. CT scans were obtained with the patient in the supine position, with 0.5-cm images taken at every 0.5 cm. To check for potential arch interference, the largest prostate cross-section was overlaid on the narrowest portion of the pubic arch. The overlap of the pubic arch and the prostate margin is measured at right angles to the inner pubic surface. The prostate volume obtained from the TRUS images was compared with the degree of pubic arch interference in order to determine whether TRUS volume predicted for interference.
RESULTS: There was considerable variability in pubic arch interference between patients. The mm of pubic arch overlap with the prostatic margin varied from -11 mm to 20 mm. Patients with larger prostate volumes generally had more pubic arch interference, but the degree of interference was only loosely related to the prostate volume (r = 0.46).
CONCLUSIONS: The degree of pubic arch interference is highly variable from one patient to the next and the TRUS volume cannot reliably predict patients who do or do not need a pelvic CT to detect potential arch interference.

Entities:  

Mesh:

Year:  1999        PMID: 10078640     DOI: 10.1016/s0360-3016(98)00466-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.

Authors:  Geoffrey V Martin; Thomas J Pugh; Usama Mahmood; Rajat J Kudchadker; Jihong Wang; Teresa L Bruno; Tharakeswara Bathala; Pierre Blanchard; Steven J Frank
Journal:  Brachytherapy       Date:  2017-05-10       Impact factor: 2.362

2.  Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imaging.

Authors:  Geoffrey V Martin; Thomas J Pugh; Usama Mahmood; Rajat J Kudchadker; Jihong Wang; Teresa L Bruno; Tharakeswara Bathala; Steven J Frank
Journal:  Brachytherapy       Date:  2017-03-09       Impact factor: 2.362

3.  Predicting pubic arch interference in permanent prostate brachytherapy based on the specific parameters derived from nuclear magnetic resonance imaging.

Authors:  Yupeng Zheng; Jixiang Wu; Shan Chen; Yuexin Liu; Guangyin Zhang
Journal:  J Contemp Brachytherapy       Date:  2018-10-25

4.  Axially rigid steerable needle with compliant active tip control.

Authors:  M de Vries; J Sikorski; S Misra; J J van den Dobbelsteen
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

5.  Predicting pubic arch interference in prostate brachytherapy on transrectal ultrasonography-computed tomography fusion images.

Authors:  Junichi Fukada; Naoyuki Shigematsu; Jun Nakashima; Toshio Ohashi; Osamu Kawaguchi; Mototsugu Oya
Journal:  J Radiat Res       Date:  2012-07-05       Impact factor: 2.724

Review 6.  Localized prostate cancer: brachytherapy.

Authors:  Anthony L Zietman
Journal:  Curr Treat Options Oncol       Date:  2002-10

7.  Image-guided therapy system for interstitial gynecologic brachytherapy in a multimodality operating suite.

Authors:  Jan Egger
Journal:  Springerplus       Date:  2013-08-21

8.  Variability in MRI vs. ultrasound measures of prostate volume and its impact on treatment recommendations for favorable-risk prostate cancer patients: a case series.

Authors:  Yonina R Murciano-Goroff; Luciant D Wolfsberger; Arti Parekh; Fiona M Fennessy; Kemal Tuncali; Peter F Orio; Thomas R Niedermayr; W Warren Suh; Phillip M Devlin; Clare Mary C Tempany; Emily H Neubauer Sugar; Desmond A O'Farrell; Graeme Steele; Michael O'Leary; Ivan Buzurovic; Antonio L Damato; Robert A Cormack; Andriy Y Fedorov; Paul L Nguyen
Journal:  Radiat Oncol       Date:  2014-09-09       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.